Magnesium in PDB 6kj6: Cryo-Em Structure of Escherichia Coli Crl Transcription Activation Complex

All present enzymatic activity of Cryo-Em Structure of Escherichia Coli Crl Transcription Activation Complex:
2.7.7.6;

The structure of Cryo-Em Structure of Escherichia Coli Crl Transcription Activation Complex also contains other interesting chemical elements:

Zinc

(Zn)

2 atoms

The binding sites of Magnesium atom in the Cryo-Em Structure of Escherichia Coli Crl Transcription Activation Complex (pdb code 6kj6). This binding sites where shown within 5.0 Angstroms radius around Magnesium atom.
In total only one binding site of Magnesium was determined in the Cryo-Em Structure of Escherichia Coli Crl Transcription Activation Complex, PDB code: 6kj6:

Magnesium binding site 1 out of 1 in the Cryo-Em Structure of Escherichia Coli Crl Transcription Activation Complex


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 1 of Cryo-Em Structure of Escherichia Coli Crl Transcription Activation Complex within 5.0Å range: probe atom residue distance (Å) B Occ I:Mg101 b:40.7 occ:1.00 O3' I:A17 2.1 47.5 1.0 O2' I:A17 2.1 47.5 1.0 OD1 D:ASP464 2.1 28.9 1.0 OD1 D:ASP460 2.5 36.0 1.0 C3' I:A17 2.8 47.5 1.0 CG D:ASP464 2.9 28.9 1.0 C2' I:A17 2.9 47.5 1.0 OD2 D:ASP464 2.9 28.9 1.0 C4' I:A17 3.2 47.5 1.0 O D:ASP460 3.6 47.5 1.0 OD2 D:ASP462 3.6 37.5 1.0 CG D:ASP460 3.7 36.0 1.0 CB D:ASP462 3.9 37.5 1.0 O4' I:A17 4.0 47.5 1.0 C1' I:A17 4.0 47.5 1.0 NH2 D:ARG425 4.0 47.5 1.0 CG D:ASP462 4.1 37.5 1.0 CB D:ASP464 4.3 28.9 1.0 OD2 D:ASP460 4.4 36.0 1.0 C5' I:A17 4.5 47.5 1.0 C D:ASP460 4.5 47.5 1.0 N D:ASP460 4.6 47.5 1.0 CA D:ASP464 4.8 47.5 1.0 N D:ASP462 4.8 47.5 1.0 N D:ASP464 4.9 47.5 1.0 CA D:ASP460 4.9 47.5 1.0 CB D:ASP460 4.9 36.0 1.0 CA D:ASP462 5.0 47.5 1.0

J.Xu, K.Cui, L.Shen, J.Shi, L.Li, L.You, C.Fang, G.Zhao, Y.Feng, B.Yang, Y.Zhang. Crl Activates Transcription By Stabilizing Active Conformation of the Master Stress Transcription Initiation Factor. Elife V. 8 2019.
ISSN: ESSN 2050-084X
PubMed: 31846423
DOI: 10.7554/ELIFE.50928